Summaries of health policy coverage from major news organizations

Drug Company To Pay $95M To Settle Improper Promotion Allegations

The Associated Press/Washington Post: Pharmaceutical Company to Pay $95M To Settle Allegations Of Improper Drug Promotion
Boehringer Ingelheim Pharmaceuticals Inc. will pay $95 million to settle allegations that the company promoted three drugs for uses that were not medically accepted, the government announced Thursday. The Justice Department said the three are the stroke-prevention drug Aggrenox, the chronic obstructive pulmonary disease drug Combivent and the high-blood-pressure drug Micardis (10/25).

This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.